Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study.
暂无分享,去创建一个
A. Nielsen | B. V. Jensen | L. Borris | E. Hørlyck | C. Tørholm | P. B. Thomsen | M. Lassen | H. P. Jensen | J. Nielsen | J. Moller | P. S. Jørgensen | B. Anderson | H. P. Skejø Bro | G. Andersen | A. Petersen | P. Siem | B. Hansen | J. Erin-Madsen | L. Rotwitt | F. Christensen | B. Paaske | P. Hvidt | N. Jensen | E. Appelquist | E. Tjalve | Holger Bro | A. B. Nielsen | D. Mortensen | A. B. Nielsen | J. Erin-madsen | H. Jensen | B.V Jensen | O. Hansen
[1] D. Murray,et al. Thromboprophylaxis and death after total hip replacement. , 1996, The Journal of bone and joint surgery. British volume.
[2] D. Bergqvist,et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. , 1996, The New England journal of medicine.
[3] M. Prins,et al. Major orthopaedic surgery and post-discharge DVT , 1996, The Lancet.
[4] A. Planès,et al. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo , 1996, The Lancet.
[5] W. Nieuwenhuizen,et al. Haemostatic Activation before and after Surgery in Patients with and without Gastric Malignancy , 1994, Thrombosis and Haemostasis.
[6] A. Nicolaides,et al. Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK. , 1992, International angiology : a journal of the International Union of Angiology.
[7] O. Huber,et al. Postoperative pulmonary embolism after hospital discharge. An underestimated risk. , 1992, Archives of surgery.
[8] M. Goldacre,et al. Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality. , 1991, BMJ.
[9] L. Jørgensen,et al. Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplasty. , 1991, Thrombosis research.
[10] Michael J. Zappa,et al. Value of the ventilation/perfusion scan in acute pulmonary embolism: Results of the prospective investigation of pulmonary embolism diagnosis , 1991 .
[11] A. Skolnick. New osteoporosis therapies appear closer. , 1990, JAMA.
[12] L. Borris,et al. Comparison of Real-Time B-Mode Ultrasonog raphy and Bilateral Ascending Phlebography for Detection of Postoperative Deep Vein Thrombosis Following Elective Hip Surgery , 1989, Thrombosis and Haemostasis.
[13] J. Hasty,et al. Deep venous thrombosis: a continuing problem. , 1988, BMJ.
[14] B. Zachrisson,et al. Phlebographic Signs in Fresh Postoperative Venous Thrombosis of the Lower Extremity , 1973, Acta radiologica: diagnosis.
[15] K. Rabinov,et al. Roentgen diagnosis of venous thrombosis in the leg. , 1972, Archives of surgery.
[16] S. Sevitt,et al. Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur. , 1959, Lancet.
[17] H. Arnesen,et al. Prolonged Thromboprophylaxis Following Hip Replacement Surgery – Results of a Double-blind, Prospective, Randomised, Placebo-controlled Study with Dalteparin (Fragmin®) , 1997, Thrombosis and Haemostasis.
[18] B. Eriksson,et al. Survival in patients undergoing total hip arthroplasty in relation to thromboprophylaxis with low molecular weight heparin: a long-term follow-up study. , 1996, The International journal of risk & safety in medicine.
[19] L. Lonnerblad. Zwei Folle von Mageninv Agination , 1933 .